Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Blood and marrow transplant handbook : comprehensive guide for patient care / / Richard T. Maziarz, Susan Schubach Slater, editors
| Blood and marrow transplant handbook : comprehensive guide for patient care / / Richard T. Maziarz, Susan Schubach Slater, editors |
| Edizione | [3rd ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XX, 1006 p. 69 illus., 43 illus. in color.) |
| Disciplina | 617.44 |
| Soggetto topico |
Hematopoietic stem cells - Transplantation
Hematopoietic stem cells - Transplantation - Nursing Hematopoietic Stem Cell Transplantation - Nursing |
| ISBN | 3-030-53626-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Overview of Hematopoietic Stem Cell Transplantation & Cellular Therapy -- The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation -- Hematopoietic Stem Cell Sources and Donor Selection -- Pre-transplant Assessment for Hematopoietic Stem Cell Transplantation Recipients and Donors -- Social Work: Evaluation and Social Supports -- Conditioning Regimens -- Nutrition -- Physical and Occupational Therapy -- Adolescent and Young Adult Concerns -- Infection Prevention and Prophylaxis -- Graft-versus-Host Disease (GvHD) Prophylaxis -- Transfusion Medicine -- Anticoagulation and Antiplatelet Guidelines -- Engraftment -- Acute Myeloid Leukemia and Allogeneic Hematopoietic Stem Cell Transplant -- Acute Lymphoblastic Leukemia -- Hodgkin Lymphoma and non-Hodgkin Lymphoma -- Multiple Myeloma -- HSCT for Germ Cell Tumors -- Hematopoietic Stem Cell Transplant for Myelofibrosis -- Chronic Myeloid Leukemia -- Chronic Lymphocytic Leukemia -- Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia -- Inherited Disorders -- Hematopoietic Cell Transplant and Cellular Therapies for Sickle Cell Disease -- Radiology Pearls for the Transplant Provider -- Acute Graft-Versus-Host Disease (GvHD) -- Chronic Graft-versus-Host Disease -- Immune Reconstitution -- Infectious Complications -- Oral Complications -- Gastrointestinal Complications -- Pulmonary Complications -- Cardiovascular Complications -- Kidney Disease in Hematopoietic Stem Cell Transplantation -- Neurological Complications -- Endocrine Complications following Hematopoietic Stem Cell Transplantation -- Thrombotic Microangiopathies -- Women’s Health Care -- Men’s Health for Bone Marrow Transplant Patients -- Psychiatric Complications -- Graft Failure -- Second Primary Malignancies -- Relapse after Hematopoietic Stem Cell Transplantation -- Safe Pain Management with Opioids in Post-Transplant Patients -- Complementary Medicine: Acupuncture -- Complementary Medicine -- Complementary Medicine: Cannabinoids and the Hematopoietic Stem Cell Transplant (HSCT) Recipient -- Management of Neurocognitive Effects and Fatigue During and After Stem Cell Transplant -- Palliative Care -- Long-Term Follow Up and Survivorship -- CAR T Cells for Hematologic Malignancies -- Natural Killer Cell Therapy in Allogeneic Stem Cell Transplant -- Mesenchymal stromal cells: Impact on hematopoietic cell transplantation -- T cell Therapeutics: Donor Lymphocyte Infusion, Cytotoxic T Lymphocyte Infusion and Other Non-CAR T cell Therapies -- Dendritic Cell Vaccines -- BiTEs, DARTs and Peri-Transplant Minimal Residual Disease -- CAR T Toxicity Management: Cytokine Release Syndrome and Neurotoxicity -- Molecular testing for post-transplant surveillance -- Management of Immune Compromised Transplant and Immune Effector Cell Treated Patients in the Setting of the COVID-19 Viral Pandemic: the OHSU Experience -- Appendix 1: The Vocabulary of Transplant -- Appendix 2: Procedure - Bone Marrow Aspirate and Biopsy -- Appendix 3: Procedure - Lumbar Puncture -- Appendix 4: Procedure - Ommaya reservoir tap -- Appendix 5: Procedure - Skin Biopsy -- Appendix 6: OHSU Food Safe Diet -- Appendix 7: OHSU Low Bacteria Diet -- Appendix 8: OHSU’s Graft-versus-host disease diet -- Appendix 9: OHSU vaccine guidelines -- Appendix 10: OHSU Donor and stem cell source selection in allogeneic hematopoietic progenitor cell transplantation. |
| Record Nr. | UNINA-9910483670303321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Blood and marrow transplantation long term management : survivorship after transplant / / edited by Bipin N Savani, André Tichelli
| Blood and marrow transplantation long term management : survivorship after transplant / / edited by Bipin N Savani, André Tichelli |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , [2021] |
| Descrizione fisica | 1 online resource (467 pages) |
| Disciplina | 617.44 |
| Soggetto topico |
Bone marrow - Transplantation
Hematopoietic stem cells - Transplantation |
| ISBN |
1-119-61273-X
1-119-61278-0 1-119-61274-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910555076103321 |
| Hoboken, New Jersey : , : Wiley-Blackwell, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Blood and marrow transplantation long term management : survivorship after transplant / / edited by Bipin N Savani, Andre Tichelli
| Blood and marrow transplantation long term management : survivorship after transplant / / edited by Bipin N Savani, Andre Tichelli |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , [2021] |
| Descrizione fisica | 1 online resource (467 pages) |
| Disciplina | 617.44 |
| Soggetto topico |
Bone marrow - Transplantation
Hematopoietic stem cells - Transplantation |
| Soggetto non controllato |
Surgery
Medical |
| ISBN |
1-119-61273-X
1-119-61278-0 1-119-61274-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | List of contributors -- Section 1 Late effects concepts -- 1 Introduction -- Bipin N Savani and Andre Tichelli -- 2 International Blood and Marrow registries trends on long-term data collection -- Rachel Phelan, Jakob Passweg, Helen Baldomero, Minako Iida, Yoshiko Atsuta, Shinichiro Okamoto, Mahmoud Aljurf, Feras Alfraih, and Bronwen Shaw -- 3 Long-term transplant clinic setup -- André Tichelli, Bipin Savani, Shahrukh K Hashmi, Navneet S Majhail, and Alicia Rovó -- 4 Telemedicine in patient care of long-term survivors -- Catherine Lee, Mihkaila Wickline, and Mary Flowers -- 5 Long-term follow-up calendar -- André Tichelli, Bipin N Savani, Shahrukh K Hashmi, Navneet S Majhail, and Alicia Rovó -- 6 Late effects after allogeneic hematopoietic stem cell transplantation -- Shahrukh Hashmi and Yoshihiro Inamoto -- 7 Late effects after autologous hematopoietic stem cell transplantation -- Rajshekhar Chakraborty and Betty Hamilton -- 8 Long-term follow-up of children -- Paul Carpenter -- 9 Graft-versus-host disease and GvHD-associated late effects -- David Michonneau, Aurélien Sutra-del-Galy, and Gérard Socié -- 10 Screening and prevention guidelines for hematopoietic cell transplant survivors -- Neel S Batt, J Douglas Rizzo, and Navneet S Majhail -- 11 Biology of survivorship after BMT -- Smita Bhatia -- Section 2 Specific late effects -- 12 Secondary malignancies -- Aurélien Sutra-del-Galy, David Michonneau, and Gérard Socié -- 13 Anti-infective prophylaxis, immunization and prevention of late infectious complications -- Per Ljungman -- 14 Seasonal virus infections in recipients and exposure to family members -- Nosha Farhadfar, Zeina Al-Mansour, and John Wingard -- 15 Monitoring and management of hepatitis B, C, and HIV infection before and after transplantation -- Enric Carreras and Montserrat Rovira -- 16 Skin chronic graft-versus-host disease -- Attilio Oliveri and Andrea Bacigalupo -- 17 Ocular complications -- Alicia Rovó, André Tichelli, and Yoshihiro Inamoto -- 18 Oral and dental complications -- Hildegard Greinix -- 19 Thyroid late complications -- Juliana Matthews, Leslee Matheny, and Shubhada Jagasia -- 20 Pre-transplant considerations in gender, reproductive, and sexual health -- Dana Shanis, Jeanne Murphy, Kate Debiec, Betty K Hamilton, Shawna Boyle, and Pamela Stratton -- 21 Post-transplant considerations in gender, reproductive, and sexual health -- Jeanne Murphy, Dana Shanis, Kate Debiec, Betty K Hamilton, Shawna Boyle, and Pamela Stratton -- 22 Fertility issues, fertility preservation, and pregnancy outcome in long-term survivors -- Alicia Rovó, Alison W Loren, André Tichelli, and Nina Salooja -- 23 Sexual dysfunction in long-term survivors -- Rebecca Hunter, Sarah Thilges, Janna Gordon, Kristy Luke, Karla Cavazos, Emilee Moeke, Colleen Bruen, and Sunita Natha -- 24 Non-infectious pulmonary late complications -- Ayman O Soubani -- 25 Cardiac and arterial complications -- Alicia Rovó and André Tichelli -- 26 Cardiovascular risk factors -- Kimberley Doucette and Minoo Battiwalla -- 27 Gastrointestinal complications -- Sumona Bhattacharya, Steven Pavletic and Theo Heller -- 28 Hepatic complications -- Christy Ann L Gilman Christopher Koh, Steven Pavletic, and Theo Heller -- 29 Renal complications -- Insara Jaffer Sathick, and Sangeeta Hingorani -- 30 Post-Transplantation Bone Disease -- Christine Ducan -- 31 Neurological late complications -- Enrico Maffini -- 32 Neurogognitive dysfunction -- David Buchbinder -- 33 Psychological distress -- Anna Barata, Aasha I Hoogland and Heather SL Jim -- 34 Persistent chronic fatigue -- Sandy Mitchell -- 35 Social issues -- Sanghee Hong and Navneet Majhail -- 36 Health-related quality of life in adult and pediatric survivors -- Lori Wiener, Jenny Hoag, and Tamryn Gray -- Section 3 Supportive care and patients reported outcome -- 37 Immunosuppressive agents and monitoring in long-term survivors -- Katie Culos and Katie Gatwood -- 38 Nutritional support and nutritional supplementation -- Shigeo Fuji -- 39 Daily routines and healthy lifestyle guidelines -- Melissa Logue -- 40 Prevalent psychosocial adjustment issues and solutions: lifestyle and social challenges -- Katrina Stokes -- 41 Complementary and alternative medicine in HSCT -- Ibrahim N Muhsen, Bipin N Savani, and Shahrukh Hashmi -- 42 Impact of adherence in outcome of long-term survivors -- Corien Eeltink and Annika Kisch -- 43 Prominent role of allied health professionals -- Catherine E Lucid -- 44 Patient reported outcome -- Hélène Schoemans -- 45 Caregivers of long-term survivors -- Angela Moreschi Woods -- 46 Patient's perspective: memory of a recovered lymphomaniac -- Michael Brown -- Appendix 1 Commonly used transplant-related medications in long-term survivors -- Katie Culos and Katie Gatwood -- Appendix 2 The eGVHD App -- Hélène Schoemans -- Index. |
| Record Nr. | UNINA-9910830159803321 |
| Hoboken, New Jersey : , : Wiley-Blackwell, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bone marrow transplantation
| Bone marrow transplantation |
| Pubbl/distr/stampa | [Houndmills, Basingstoke, Hampshire, UK], : Stockton Press |
| Descrizione fisica | 1 online resource |
| Disciplina | 617.44 |
| Soggetto topico |
Bone marrow - Transplantation
Bone Marrow Transplantation Moelle osseuse - Greffe Beenmergtransplantatie |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1476-5365 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996336721003316 |
| [Houndmills, Basingstoke, Hampshire, UK], : Stockton Press | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Bone marrow transplantation
| Bone marrow transplantation |
| Pubbl/distr/stampa | Basingstoke, : Macmillan |
| Disciplina |
617.44
619 |
| ISSN | 0268-3369 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-990008925950403321 |
| Basingstoke, : Macmillan | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bone marrow transplantation
| Bone marrow transplantation |
| Pubbl/distr/stampa | [Houndmills, Basingstoke, Hampshire, UK], : Stockton Press |
| Descrizione fisica | 1 online resource |
| Disciplina | 617.44 |
| Soggetto topico |
Bone marrow - Transplantation
Bone Marrow Transplantation Moelle osseuse - Greffe Beenmergtransplantatie |
| Soggetto genere / forma |
Periodical
Periodicals. |
| ISSN | 1476-5365 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910147347103321 |
| [Houndmills, Basingstoke, Hampshire, UK], : Stockton Press | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bone marrow-derived progenitors / contributors M. Andreeff...[et al.] ; editors Katalin Kauser and Andreas-Michael Zeiher
| Bone marrow-derived progenitors / contributors M. Andreeff...[et al.] ; editors Katalin Kauser and Andreas-Michael Zeiher |
| Pubbl/distr/stampa | Berlin ; Heidelberg : copyr. 2007 |
| Descrizione fisica | VIII, 289 p. ; 24 cm |
| Disciplina | 617.44 |
| Collana | Handbook of experimental pharmacology |
| Soggetto topico |
Midollo osseo - Trapianto
Cellule staminali - Impiego |
| ISBN | 978-3-540-68975-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990002960550203316 |
| Berlin ; Heidelberg : copyr. 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone
| Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone |
| Autore | Comandone Alessandro |
| Pubbl/distr/stampa | Torino, : SEEd, 2011 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina |
617.4/4
617.44 |
| Soggetto topico |
Tumors
Chemotherapy |
| Soggetto genere / forma | Electronic books. |
| ISBN | 88-97419-08-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin
Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB Testicular tumors: VeIP (rescue regimen) |
| Record Nr. | UNINA-9910457486903321 |
Comandone Alessandro
|
||
| Torino, : SEEd, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone
| Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone |
| Autore | Comandone Alessandro |
| Pubbl/distr/stampa | Torino, : SEEd, 2011 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina |
617.4/4
617.44 |
| Soggetto topico |
Tumors
Chemotherapy |
| ISBN | 88-97419-08-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin
Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB Testicular tumors: VeIP (rescue regimen) |
| Record Nr. | UNINA-9910778948203321 |
|
Comandone Alessandro
|
||
| Torino, : SEEd, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemotherapy regimens in rare solid tumors / / Alessandro Gommandone
| Chemotherapy regimens in rare solid tumors / / Alessandro Gommandone |
| Autore | Comandone Alessandro |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Torino, : SEEd, 2011 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina |
617.4/4
617.44 |
| Soggetto topico |
Tumors
Chemotherapy |
| ISBN | 88-97419-08-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin
Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB Testicular tumors: VeIP (rescue regimen) |
| Record Nr. | UNINA-9910823576103321 |
|
Comandone Alessandro
|
||
| Torino, : SEEd, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
